捷健康完成了Canalevia- CA1的有效性试验,用于治疗犬类化疗引起的腹. Jaguar Health completes effectiveness trial for Canalevia-CA1 to treat dog chemotherapy-induced diarrhea.

捷健康公司已经完成了其Canalevia-CA1药物的有效性试验,该药物旨在治疗犬类化学疗法引起的腹. Jaguar Health has completed an effectiveness trial for its drug Canalevia-CA1, designed to treat chemotherapy-induced diarrhea in dogs. 该研究支持为该产品寻求FDA的全面批准,目前该产物已获得条件批准. The study supports seeking full FDA approval for the product, which is currently conditionally approved.